Cellectar Biosciences Competitors and Similar CompaniesClear all

Cellectar Biosciences's competitors and similar companies include Inventiva, Rgenta, Protagonist Therapeutics and TauRx.

	Cellectar Biosciences Cellectar Biosciences (formerly Novelos Therapeutics) is a clinical biopharmaceutical company that focuses on the discovery, development, and commercialization of drugs for the treatment of cancer.	Inventiva Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases.	Rgenta Rgenta Therapeutics is a company developing RNA-targeting medicines focused on oncology and neurological disorders.	Protagonist Therapeutics Protagonist Therapeutics is a biopharmaceutical company engaged in discovering and developing peptide-based therapeutic drugs.	TauRx TauRx is a company specializing in Alzheimer's disease research.
Founding Date	Founding Date 1996	Founding Date 2011	Founding Date 2020	Founding Date 2006	Founding Date 2002
Type	Type Public	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech clinical research drug development medical diagnostics oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma platform	Tags Healthcare biotech clinical research drug development pharma platform	Tags Healthcare biotech clinical research drug development medical diagnostics pharma
Locations	Locations Florham Park, US HQ	Locations Daix, FR HQ	Locations Woburn, US HQ	Locations Newark, US HQ Saint Lucia, AU	Locations Singapore, SG HQ Aberdeen, GB Aberdeen, GB
Employees	Employees 1145% decrease	Employees 114	Employees 299% decrease	Employees 12613% increase	Employees 801% increase
Valuation ($)	Valuation ($) 73.7 m	Valuation ($) 231 m	Valuation ($) N/A	Valuation ($) 2.9 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €4.5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $46m (FY, 2025)	Revenue (est.) N/A
Net income	Net income ($21.8m) (FY, 2025)	Net income (€354.1m) (FY, 2025)	Net income N/A	Net income ($130.1m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 28.3m	Total funding raised $ 10.5m